Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (465131031)
HORIZON EUROPE Marie Sklodowska-Curie Actions (813716)
Medizinische Hochschule Hannover (MHH)
Article History
Received: 3 May 2023
Revised: 8 December 2023
Accepted: 8 December 2023
First Online: 3 January 2024
Declarations
:
: The authors declare that they have no competing interests. TT filed and licensed patents in the field of noncoding RNAs. TT is founder and shareholder of Cardior Pharmaceuticals GmbH.